These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22510399)

  • 1. Universal lipid screening in children and adolescents: a baby step toward primordial prevention?
    Saenger AK
    Clin Chem; 2012 Aug; 58(8):1179-81. PubMed ID: 22510399
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid screening and treatment recommendations for children and adolescents.
    McBride PE; Kavey RE
    Pediatr Ann; 2012 Jul; 41(7):1-10. PubMed ID: 22765031
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid Screening in Children and Adolescents.
    Urbina EM; de Ferranti SD
    JAMA; 2016 Aug; 316(6):589-91. PubMed ID: 27532913
    [No Abstract]   [Full Text] [Related]  

  • 4. Updated guidelines for lipid screening in children and adolescents.
    Howard T; Grosel J
    JAAPA; 2015 Mar; 28(3):30-6. PubMed ID: 25675326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAMA PATIENT PAGE. Screening for Lipid Disorders in Children and Adolescents.
    Livingston EH
    JAMA; 2016 Aug; 316(6):678. PubMed ID: 27532934
    [No Abstract]   [Full Text] [Related]  

  • 6. Universal screening and drug treatment of dyslipidemia in children and adolescents.
    Psaty BM; Rivara FP
    JAMA; 2012 Jan; 307(3):257-8. PubMed ID: 22174386
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians.
    de Ferranti SD; Rodday AM; Parsons SK; Cull WL; O'Connor KG; Daniels SR; Leslie LK
    J Pediatr; 2017 Jun; 185():99-105.e2. PubMed ID: 28209292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of guidelines for dyslipidemia in children and adolescents.
    Peterson AL; McBride PE
    WMJ; 2012 Dec; 111(6):274-81; quiz 282. PubMed ID: 23362704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk.
    Sulkes D; Brown BG; Krauss RM; Segrest JP; Sniderman AD; Roberts WC
    Am J Cardiol; 2008 Mar; 101(6):828-42. PubMed ID: 18328849
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening adolescents for lipid disorders: what is the best approach?
    Jenssen BP; Jacobson MS
    Adolesc Med State Art Rev; 2008 Dec; 19(3):507-20, x. PubMed ID: 19227389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Screening in Children: Low-Value Care.
    Newman TB; Schroeder AR; Pletcher MJ
    JAMA Intern Med; 2016 Oct; 176(10):1437-1438. PubMed ID: 27533131
    [No Abstract]   [Full Text] [Related]  

  • 12. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs?
    Lipshultz SE; Schaechter J; Carrillo A; Sanchez J; Qureshi MY; Messiah SE; Hershorin ER; Wilkinson JD; Miller TL
    Pediatr Endocrinol Rev; 2012 Aug; 9(4):698-705. PubMed ID: 23304806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal Lipid Screening in 9- to 11-Year-Olds Before and After 2011 Guidelines.
    Mihalopoulos NL; Stipelman C; Hemond J; Brown LL; Young PC
    Acad Pediatr; 2018 Mar; 18(2):196-199. PubMed ID: 29180296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Disorders: Screening and Treatment.
    Jin J
    JAMA; 2016 Nov; 316(19):2056. PubMed ID: 27838718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present Execution of and Problems with Clinical Lipid Examination and Application of "the Japan Atherosclerotic Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012"].
    Igarashi M; Tanji Y; Nomura T; Yamaguchi H
    Rinsho Byori; 2014 Sep; 62(9):884-91. PubMed ID: 27526534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians' Lack of Adherence to National Heart, Lung, and Blood Institute Guidelines for Pediatric Lipid Screening.
    Valle CW; Binns HJ; Quadri-Sheriff M; Benuck I; Patel A
    Clin Pediatr (Phila); 2015 Oct; 54(12):1200-5. PubMed ID: 25813383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating the new lipid guidelines into practice.
    Spear S
    JAAPA; 2014 Jun; 27(6):11. PubMed ID: 24803202
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular risk in young persons: secondary or primordial prevention?
    Berenson GS; Srinivasan SR
    Ann Intern Med; 2010 Aug; 153(3):202-3. PubMed ID: 20679564
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric dyslipidemia: recommendations for clinical management.
    Wilson DP; McNeal C; Blackett P
    South Med J; 2015 Jan; 108(1):7-14. PubMed ID: 25580750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.